100X Gains On Tap as Under-the-Radar Green-Tech Stock Soars
Searching for the next 1,000% stock winner? Look no further than key Green-Techs that are driving the EV, Solar & 5G booms. Silver is the #1 element in the Green Energy Revolution & we’ve found the top silver gem – undiscovered at 10-cents per share – that’s fueling the path to a carbon-free world.
Get the details here...
pixel
Jay T Flatley, insider at Illumina

Jay T Flatley Insider Information

Director of Illumina

Jay Flatley is the former CEO and director of Illumina. He currently serves as executive chairman. 

During his time as CEO, Flatley directed the company’s expansion from microarrays to next-generation sequencing via its 2006 acquisition of Solexa, and more recently from research to clinical and applied markets.  

Prior to Illumina, Flatley was co-founder, president, CEO, and a director for Molecular Dynamics, a life sciences company concentrated on genetic discovery and analysis. He remained there until the company’s sale to Amersham Pharmacia Biotech in 1998. 

Previously, he served as vice president of engineering and vice president of strategic planning for Plexus Computers. He was also a director for Coherent, a photonics-based solutions provider for commercial and scientific markets. 

During Flatley’s tenure at Illumina, the company was recognized multiple times on the Deloitte & Touche “Fast 50” and “Fast 500” lists, and Forbes’ list of the “25 Fastest-Growing Tech Companies” in 2007, 2009 and 2010. It was also named to Fortune’s “100 Fastest-Growing Companies” list in 2010 and 2011. Additionally, MIT Technology Review recognized it as the “World’s Smartest Company” in 2014. 

Flatley received his bachelor of arts in economics from Claremont McKenna College. He also received both his bachelor of science and master of science in industrial engineering at Stanford University.

Within the last three months, Jay T. Flatley has sold $1,693,760.00 in Illumina stock. Most recently, Jay T. Flatley sold 4,000 shares of the business's stock in a transaction on Tuesday, April 6th. The shares were sold at an average price of $423.44, for a transaction totalling $1,693,760.00.

Read More

Jay T Flatley Insider Trading History at Illumina

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/6/2021Sell4,000$423.44$1,693,760.00
3/16/2021Sell4,000$421.06$1,684,240.00164,933  
1/19/2021Sell4,000$382.48$1,529,920.00180,933  
1/5/2021Sell4,000$365.27$1,461,080.00184,933  
12/15/2020Sell4,000$348.84$1,395,360.00188,933  
12/1/2020Sell4,000$323.90$1,295,600.00
11/17/2020Sell3,000$297.16$891,480.00197,933  
10/20/2020Sell4,000$321.72$1,286,880.00203,933  
10/6/2020Sell3,000$317.79$953,370.00207,933  
9/15/2020Sell4,000$355.22$1,420,880.00210,933  
9/1/2020Sell4,000$355.35$1,421,400.00214,933  
8/18/2020Sell4,000$354.03$1,416,120.00218,933  
7/21/2020Sell4,000$399.00$1,596,000.00226,933  
7/7/2020Sell4,000$370.22$1,480,880.00230,933  
6/16/2020Sell4,000$354.93$1,419,720.00234,933  
5/19/2020Sell4,000$342.34$1,369,360.00241,970  
5/5/2020Sell3,000$310.37$931,110.00245,970  
4/21/2020Sell3,000$310.77$932,310.00248,970  
4/7/2020Sell2,000$284.63$569,260.00255,970  
2/18/2020Sell3,000$299.00$897,000.00255,970  
8/28/2019Sell3,300$283.41$935,253.00262,733  
7/24/2019Sell3,300$304.00$1,003,200.00269,316  
7/10/2019Sell3,300$376.50$1,242,450.00272,616  
6/26/2019Sell3,300$358.15$1,181,895.00275,916  
6/12/2019Sell3,300$334.53$1,103,949.00279,216  
5/22/2019Sell3,300$304.44$1,004,652.00282,516  
5/8/2019Sell3,300$318.59$1,051,347.00285,816  
4/10/2019Sell3,300$317.01$1,046,133.00331,668  
3/27/2019Sell3,300$306.93$1,012,869.00338,268  
3/13/2019Sell3,300$306.50$1,011,450.00338,268  
2/27/2019Sell3,300$300.00$990,000.00341,568  
2/13/2019Sell3,300$293.66$969,078.00358,929  
1/23/2019Sell3,300$303.53$1,001,649.00329,979  
1/9/2019Sell3,300$296.20$977,460.00333,279  
12/26/2018Sell3,300$273.87$903,771.00339,879  
12/12/2018Sell3,300$334.13$1,102,629.00374,859  
11/28/2018Sell3,300$321.80$1,061,940.00373,410  
11/14/2018Sell3,300$312.50$1,031,250.00376,710  
10/24/2018Sell3,300$310.58$1,024,914.00382,304  
10/10/2018Sell3,300$321.58$1,061,214.00385,604  
9/26/2018Sell3,300$360.81$1,190,673.00388,904  
9/12/2018Sell3,300$351.66$1,160,478.00392,204  
1/16/2018Sell15,000$243.72$3,655,800.00449,201  
1/2/2018Sell20,000$223.40$4,468,000.00463,436  
12/19/2017Sell20,000$215.48$4,309,600.00480,476  
12/5/2017Sell20,000$212.55$4,251,000.00505,980  
11/21/2017Sell20,000$211.35$4,227,000.00531,717  
11/7/2017Sell20,000$210.59$4,211,800.00536,717  
10/24/2017Sell20,000$210.43$4,208,600.00539,176  
10/10/2017Sell20,000$203.27$4,065,400.00  
9/26/2017Sell20,000$200.16$4,003,200.00539,176  
9/12/2017Sell20,000$211.11$4,222,200.00539,176  
8/29/2017Sell22,540$195.21$4,400,033.40539,176  
8/28/2017Sell2,540$197.39$501,370.60539,176  
8/15/2017Sell20,000$194.73$3,894,600.00539,176  
8/2/2017Sell20,000$176.43$3,528,600.00534,176  
7/18/2017Sell15,000$170.77$2,561,550.00534,176  
7/5/2017Sell15,000$172.92$2,593,800.00534,176  
6/22/2017Sell20,000$178.21$3,564,200.00534,176  
6/6/2017Sell20,000$180.24$3,604,800.00539,176  
6/1/2017Sell3,320$180.55$599,426.00519,176  
5/23/2017Sell15,000$175.53$2,632,950.00534,176  
5/9/2017Sell20,000$184.14$3,682,800.00539,176  
8/23/2016Sell20,000$172.99$3,459,800.00508,061  
8/15/2016Sell10,000$170.00$1,700,000.00498,061  
8/9/2016Sell10,000$165.97$1,659,700.00498,061  
8/1/2016Sell10,000$170.00$1,700,000.00498,061  
7/26/2016Sell10,000$150.00$1,500,000.00498,061  
7/18/2016Sell10,000$150.00$1,500,000.00498,061  
4/12/2016Sell20,000$170.05$3,401,000.00508,061  
3/22/2016Sell10,000$154.18$1,541,800.00498,061  
3/8/2016Sell10,000$154.49$1,544,900.00500,915  
2/23/2016Sell10,000$152.49$1,524,900.00440,784  
8/13/2015Sell25,000$207.85$5,196,250.00  
7/23/2015Sell25,000$214.87$5,371,750.00  
7/9/2015Sell25,000$218.10$5,452,500.00  
6/25/2015Sell25,000$220.34$5,508,500.00  
6/11/2015Sell25,000$216.41$5,410,250.00  
5/28/2015Sell25,000$208.78$5,219,500.00  
5/14/2015Sell25,000$197.76$4,944,000.00  
4/23/2015Sell25,000$189.57$4,739,250.00  
4/9/2015Sell25,000$184.55$4,613,750.00  
3/26/2015Sell25,000$181.34$4,533,500.00  
2/26/2015Sell25,000$195.73$4,893,250.00  
2/12/2015Sell25,000$194.64$4,866,000.00  
1/22/2015Sell25,000$188.48$4,712,000.00  
1/8/2015Sell25,000$197.62$4,940,500.00  
12/26/2014Sell25,000$186.71$4,667,750.00  
12/11/2014Sell25,000$185.79$4,644,750.00  
11/13/2014Sell25,000$189.32$4,733,000.00  
10/23/2014Sell25,000$189.54$4,738,500.00  
10/9/2014Sell25,000$163.49$4,087,250.00  
9/25/2014Sell25,000$164.43$4,110,750.00  
9/15/2014Sell25,000$176.06$4,401,500.00  
8/28/2014Sell30,000$178.98$5,369,400.00  
7/24/2014Sell30,000$175.43$5,262,900.00  
7/10/2014Sell30,000$172.56$5,176,800.00  
6/26/2014Sell30,000$170.11$5,103,300.00  
6/12/2014Sell30,000$172.25$5,167,500.00  
10/24/2013Sell30,000$92.32$2,769,600.00  
7/25/2013Sell20,000$81.01$1,620,200.00  
7/11/2013Sell20,000$74.90$1,498,000.00  
6/27/2013Sell20,000$74.96$1,499,200.00  
6/13/2013Sell20,000$66.49$1,329,800.00  
5/21/2013Sell24,000$69.39$1,665,360.00  
5/9/2013Sell20,000$66.63$1,332,600.00  
11/8/2012Sell5,000$47.99$239,950.00  
See Full Table

Jay T Flatley Buying and Selling Activity at Illumina

Illumina Company Overview

Illumina logo
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $403.37
$394.50
$406.26

50 Day Range

MA: $417.63
$368.96
$486.26

52 Week Range

Now: $403.37
$260.42
$555.77

Volume

662,140 shs

Average Volume

1,228,311 shs

Market Capitalization

$58.85 billion

P/E Ratio

93.59

Dividend Yield

N/A

Beta

1.14
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel